Elpiscience

Developer of checkpoint inhibitors for the treatment of cancer

placePudong, Shanghai, China calendar_todayFounded 2017 groups150 employees language elpiscience.com

Social engagement

Social engagement: 1.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include Hyfinity Investments, Hillhouse, CDH, Lilly Asia Ventures.

Investor typeCountShare
Venture capital640%
Private equity427%
Other / undisclosed533%

Recent activity

12 May 2026
Milestone
regulatory
20 Mar 2026
Event
AACR2026
3 Mar 2026
Milestone
regulatory
Coming soon